anmelden
SPI Basic Resources
6.087,43
PKT
-21,54
PKT
-0,35
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Basic Resources-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.12.12 | Clariant hold | Deutsche Bank AG | |
| 07.12.12 | Givaudan sell | Deutsche Bank AG | |
| 03.12.12 | Clariant underperform | Credit Suisse Group | |
| 23.11.12 | Clariant buy | UBS AG | |
| 21.11.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 19.11.12 | Clariant neutral | HSBC | |
| 16.11.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 16.11.12 | Clariant neutral | Exane-BNP Paribas SA | |
| 16.11.12 | EMS-CHEMIE reduce | Vontobel Research | |
| 14.11.12 | Clariant buy | Vontobel Research | |
| 01.11.12 | Clariant sell | Société Générale Group S.A. (SG) | |
| 01.11.12 | Clariant buy | Vontobel Research | |
| 31.10.12 | Clariant underperform | Cheuvreux SA | |
| 31.10.12 | Clariant buy | Vontobel Research | |
| 31.10.12 | Clariant buy | Sarasin Research | |
| 26.10.12 | Clariant buy | Vontobel Research | |
| 18.10.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 18.10.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 17.10.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.10.12 | Givaudan hold | Vontobel Research | |
| 16.10.12 | Clariant buy | Vontobel Research | |
| 15.10.12 | Givaudan hold | Vontobel Research | |
| 15.10.12 | Clariant buy | Sarasin Research | |
| 15.10.12 | Clariant buy | Vontobel Research | |
| 12.10.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 11.10.12 | EMS-CHEMIE hold | Vontobel Research | |
| 10.10.12 | Givaudan equal-weight | Morgan Stanley | |
| 10.10.12 | EMS-CHEMIE hold | Vontobel Research | |
| 10.10.12 | EMS-CHEMIE buy | Sarasin Research | |
| 10.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Givaudan reduce | Nomura | |
| 09.10.12 | Givaudan neutral | Sarasin Research | |
| 09.10.12 | Givaudan hold | Vontobel Research | |
| 05.10.12 | Clariant buy | UBS AG | |
| 05.10.12 | Givaudan neutral | UBS AG | |
| 04.10.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 04.10.12 | Givaudan neutral | Credit Suisse Group | |
| 11.09.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 03.09.12 | Clariant sell | Goldman Sachs Group Inc. | |
| 03.09.12 | Givaudan sell | Goldman Sachs Group Inc. |
